Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner KM, Svedman C. Wersäll PJ, et al. Among authors: pisa p. Acta Oncol. 2006;45(4):493-7. doi: 10.1080/02841860600604611. Acta Oncol. 2006. PMID: 16760190 No abstract available.
Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Lax I, Kälkner KM, Linder C, Lundell G, Nilsson B, Nilsson S, Näslund I, Pisa P, Svedman C. Wersäll PJ, et al. Among authors: pisa p. Radiother Oncol. 2005 Oct;77(1):88-95. doi: 10.1016/j.radonc.2005.03.022. Epub 2005 Jun 20. Radiother Oncol. 2005. PMID: 15972239 Clinical Trial.
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner KM, Nilsson S, Wersäll P. Svedman C, et al. Among authors: pisa p. Acta Oncol. 2006;45(7):870-5. doi: 10.1080/02841860600954875. Acta Oncol. 2006. PMID: 16982552 Clinical Trial.
Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.
Alimov A, Sundelin B, Bergerheim U, Pavlenko M, Pisa P, Zetterberg A, Larsson C, Lagercrantz S. Alimov A, et al. Among authors: pisa p. Int J Oncol. 2004 Oct;25(4):955-60. Int J Oncol. 2004. PMID: 15375545
Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses.
Lundqvist A, Palmborg A, Bidla G, Whelan M, Pandha H, Pisa P. Lundqvist A, et al. Among authors: pisa p. Med Oncol. 2004;21(2):155-65. doi: 10.1385/MO:21:2:155. Med Oncol. 2004. PMID: 15299188
Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.
De Petris L, Bergfeldt K, Hising C, Lundqvist A, Tholander B, Pisa P, van der Zanden HG, Masucci G. De Petris L, et al. Among authors: pisa p. Med Oncol. 2004;21(1):49-52. doi: 10.1385/MO:21:1:49. Med Oncol. 2004. PMID: 15034213
Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue.
Jonmarker S, Glaessgen A, Culp WD, Pisa P, Lewensohn R, Ekman P, Valdman A, Egevad L. Jonmarker S, et al. Among authors: pisa p. APMIS. 2008 Jun;116(6):491-8. doi: 10.1111/j.1600-0463.2008.01020.x. APMIS. 2008. PMID: 18754323
Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer.
Miller AM, Ozenci V, Kiessling R, Pisa P. Miller AM, et al. Among authors: pisa p. J Immunother. 2005 Jul-Aug;28(4):389-95. doi: 10.1097/01.cji.0000165353.19171.41. J Immunother. 2005. PMID: 16000958 Clinical Trial.
Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice.
Palucka AK, Scuderi R, Porwit A, Jeha S, Gruber A, Björkholm M, Beran M, Pisa P. Palucka AK, et al. Among authors: pisa p. Leukemia. 1996 Mar;10(3):558-63. Leukemia. 1996. PMID: 8642875
Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma.
Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C, Kiessling R. Nakagomi H, et al. Among authors: pisa ek, pisa p. Int J Cancer. 1995 Nov 3;63(3):366-71. doi: 10.1002/ijc.2910630311. Int J Cancer. 1995. PMID: 7591233
148 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback